• Ticker

    Advertisement Find a Broker - Visit the DailyFinance Broker Center
DJIA 12,454.83 -74.92 -0.60%
NASDAQ 2,837.53 -1.85 -0.07%
S&P 500 1,317.82 -2.86 -0.22%

Pfizer, Inc.

NYSE:PFE

$22.13 -$0.01 (-0.05%)

REAL-TIME: Last trade at

Jump to this page for:

Related Resources

Frustrated US investors find their voice

5/28/2012 by FT.com

Pfizer says EU recommends approval of Inlyta

5/25/2012 by Product Design and Development

Chairman: Elan may get offer if Alzheimer drug data positive, Reuters says

5/25/2012 by Theflyonthewall.com

Senate passes FDA funding bill, Reuters reports

5/25/2012 by Theflyonthewall.com

Pfizer’s Axitinib Receives Positive Opinion from the Committee for Human Medicinal Products for the Second-line Treatment of Advanced Kidney Cancer in the EU

5/25/2012 by Business Wire

Perception, Opportunity in Volatility - Research & Analysis on Pfizer Inc. and Alcoa Inc.

5/25/2012 by Marketwire

FDA Advisory Committee Finds Data Support Effectiveness of Tafamidis Meglumine, Pfizer’s Novel Investigational Treatment for Transthyretin Familial Amyloid Polyneuropathy (TTR-FAP)

5/25/2012 by PharmiWeb.com - UK

FDA Advisory Committee Finds Data Support Effectiveness of Tafamidis Meglumine, Pfizer’s Novel Investigational Treatment for Transthyretin Familial Amyloid Polyneuropathy (TTR-FAP)

5/24/2012 by Business Wire

Heinz Falls After Q4 Profit Beat But It Guided Down

5/24/2012 by Investor's Business Daily

Pfizer Exec Leaving for PPD

5/24/2012 by Drug Discovery & Development

Plan to Speed Up FDA Reviews for New Drugs and Medical Devices Moved to Senate

5/24/2012 by Marketwire

FDA Peripheral & Central Nervous System Drugs Committee holds a meeting

5/24/2012 by Theflyonthewall.com

J&J's Xarelto likely delayed 3-12 months, not dead, says Leerink

5/24/2012 by Theflyonthewall.com

Pfizer Launches Lipitor Mobile App

5/24/2012 by Media Post

Pfizer: Why Now Is The Best Time To Buy

5/24/2012 by Seeking Alpha

Pharma's Rare Disease Strategy

5/23/2012 by CNBC Video

Pfizer Rare Disease Drug Slammed By FDA Reviewer

5/23/2012 by Forbes

Analysts question Biocon's treatment of Pfizer compensation

5/23/2012 by moneycontrol.com - India

Best Plays in Dividend Stocks

5/23/2012 by CNBC Video

Pfizer emerging markets head leaving for PPD

5/23/2012 by Product Design and Development

Hide from Europe's mess with dividend stocks

5/23/2012 by CNNMoney

Hisun Pharma , Pfizer Inc. to Set Up $250 Million JV

5/23/2012 by BioSpace

Pfizer, EatingWell launch Lipitor for You mobile app

5/23/2012 by Drug Store News

Research Reports for Morgan Stanley, Pfizer, Duke Energy, Walter Energy, SandRidge Energy, and Fifth Third Bancorp

5/23/2012 by PR Newswire

PPD names Pfizer vet chairman and CEO

5/23/2012 by Triangle Business Journal - Raleigh NC

PPD, Inc. names David Simmons as chairman and CEO

5/23/2012 by Theflyonthewall.com

Pfizer (PFE) Promotes Olivier Brandicourt to GM of Emerging Markets, Established Products Units

5/23/2012 by StreetInsider.com

Pfizer Names Olivier Brandicourt as President and General Manager, Emerging Markets and Established Products Business Units

5/23/2012 by Business Wire

FTC, Senate probing blocking of generic drug companies, Washington Post says

5/23/2012 by Theflyonthewall.com

Pharmaceuticals - Global Group of Eight (G8) Industry Guide

5/23/2012 by PR Newswire

FDA staff not impressed with Pfizer rare disease drug tafamidis

5/23/2012 by PharmaTimes - UK

Arthritis Therapeutics Market to 2018 - Novel Oral JAK Inhibitors and Biologic Disease Modifying Anti-Rheumatic Drugs (DMARD) Will Drive Continued Growth Across Key Indications

5/23/2012 by PR Newswire

Hisun Pharma to Set Up $250 Million JV With Pfizer Inc.

5/22/2012 by BioSpace

Pfizer still looking for Sandwich buyer as initial talks end

5/22/2012 by PharmaTimes - UK

Comparing 2 Dividend Plays In Healthcare

5/22/2012 by Seeking Alpha

Global pharma

5/22/2012 by FT.com

Pfizer Invites Public to View and Listen to Webcast of June 3 Pfizer Analyst and Investor Meeting at ASCO

5/22/2012 by PharmiWeb.com - UK

Analysis And Valuation: Johnson & Johnson, Pfizer, And Merck

5/22/2012 by Seeking Alpha

Pfizer Teams With EatingWell To Launch Free Mobile App

5/22/2012 by StockWatch

Espirito Santo questions Biocon's accounting practices

5/22/2012 by moneycontrol.com - India
See More Articles...